Skip to content
GLP-1 Savers

Price & savings guide

Foundayo (Orforglipron) Price: Every Dose, With and Without Insurance

Foundayo costs $149 to $349 a month cash by dose, as little as $25 with commercial coverage and Lilly's card, and $50 on Medicare's GLP-1 Bridge.

By Grant Ashford, Founder & Pricing Editor
What's in this guide
Featured partner

CoreAge Rx

Est. first month

$99/mo

Save ~72% vs brand self-pay

Check today's price
Semaglutide
$99/mo
Tirzepatide
$149/mo
Coverage
U.S., state limits shown at intake
Pricing
Flat — no month-two step-up
Route
Compounded injectable

We earn a commission when you start treatment through some links on this site, at no extra cost to you. It never changes the Value Score.

Foundayo (orforglipron) costs $149 to $349 a month if you pay cash through Lilly, depending on the dose. Right now the first three doses cost $149, $149 and $199, because two of them are on a temporary price cut that ends December 31, 2026. The 9 mg dose is $299. The two highest doses are $349, or $299 if you refill within 45 days of your last delivery. With commercial insurance that covers Foundayo, Lilly's savings card brings a fill down to as little as $25. Eligible Medicare Part D members pay $50 a month through the Medicare GLP-1 Bridge.

Every figure below was read on October 5, 2026, from Lilly's published savings-program terms36, the federal TrumpRx price page2, the FDA label7 and the CMS and KFF write-ups of the Medicare Bridge89. Two independent price trackers publish the same dose ladder45.

Foundayo price by dose

Foundayo comes in six tablet strengths, taken once a day7. One bottle is 30 tablets, a month's supply2.

DoseCash price todayRegular cash priceCommercial insurance + savings cardMedicare GLP-1 Bridge
0.8 mg (start)$149$149As little as $25$50
2.5 mg$149 (temporary)$199As little as $25$50
5.5 mg$199 (temporary)$299As little as $25$50
9 mg$299$299As little as $25$50
14.5 mg$299 if refilled within 45 days, else $349$349As little as $25$50
17.2 mg$299 if refilled within 45 days, else $349$349As little as $25$50

The "temporary" prices come straight from the government's TrumpRx listing, which says the 2.5 mg and 5.5 mg prices are "temporarily reduced through December 31, 2026" and gives the regular prices as $199 and $2992. Lilly's self-pay card terms print the same reduced prices and say the card "expires 12/31/2026"3. Unless Lilly extends the offer, plan on the regular column from January.

TrumpRx does not sell the drug itself. Its Foundayo page sends buyers to LillyDirect, which can deliver or transfer the prescription to a retail pharmacy2. Lilly's card terms say the self-pay prices also apply at "other participating pharmacies"3.

The 45-day rule on the top two doses

The 14.5 mg and 17.2 mg doses have two prices. The regular price is $349. You pay $299 only while you keep refilling on time: each refill has to be completed within 45 days of your previous delivery45. Miss the window, through a late appointment, a supply gap or a month you skip, and that fill costs $349.

That is a $50 swing per fill. Over a year of on-time refills at the top dose, you pay about $3,588 (12 fills at $299). With every refill late, the same year costs about $4,188.

The 9 mg dose has no such condition. It is $299 either way, which makes it the highest dose with one fixed cash price.

Why the price climbs after the first two months

The label starts everyone at 0.8 mg once daily. After at least 30 days the dose goes to 2.5 mg, and after at least another 30 days to 5.5 mg. From there your prescriber can raise it to 9 mg, 14.5 mg or 17.2 mg, one step at a time, each after at least 30 days on the current dose, depending on how well it works and how well you tolerate it7.

So the $149 headline buys the starting dose. A realistic first year, paid in cash under today's prices, looks like this:

  • Month 1 (0.8 mg): $149
  • Month 2 (2.5 mg): $149 while the promotion lasts, $199 after
  • Month 3 (5.5 mg): $199 while the promotion lasts, $299 after
  • Months 4 onward: $299 at 9 mg, or $299 to $349 at 14.5 mg and 17.2 mg, depending on refill timing

Where you settle depends on your response, not on the price list. Many people will spend most of the year in the $299 tier.

One label rule can cost you money: if you miss seven or more doses in a row, the label says to restart the dose escalation at a lower dose7. A long gap can send you back down the ladder, and back through the lower-dose bottles.

With commercial insurance: the $25 card

If your commercial (employer or individual) plan covers Foundayo, Lilly's savings card can bring a fill down to as little as $25, for a one-, two- or three-month prescription6. The limits matter:

  • The card pays up to $100 per one-month fill ($200 for two months, $300 for three)6
  • The annual maximum is $1,000, across up to 10 fills a year6
  • It excludes anyone in a government healthcare program, including Medicare and Medicaid6
  • The card expires December 31, 20266

Read that first line carefully. "As little as $25" holds when your plan's copay is $125 or less. If your plan charges $200 a month for Foundayo, the card takes off $100 and you pay $100. Once the $1,000 annual maximum is used up, you pay the plan's full copay for the rest of the year.

If your plan does not cover Foundayo, the insured card does not help. Your route is the cash ladder above, and Lilly's self-pay card terms say you cannot then seek insurance reimbursement for those purchases3. For how manufacturer cards work across GLP-1 brands, see do GLP-1 savings cards actually lower the price?

Medicare: the $50 Bridge

The Medicare GLP-1 Bridge, which runs from July 1, 2026 through December 31, 2027, lets eligible Part D members get "all formulations of both Foundayo and Wegovy and the KwikPen formulation of Zepbound" for $50 a month89.

Three conditions apply:

  • Your prescriber has to submit a prior authorization request showing you meet the program's clinical criteria8
  • You need Part D coverage through a qualifying drug plan9
  • The $50 does not count toward your Part D deductible or the $2,100 out-of-pocket maximum for 20268

For a full walk-through of who qualifies, see the Medicare GLP-1 Bridge: what it actually covers.

What a year of Foundayo costs on each route

Using a one-month fill and the 9 mg dose (one fixed price, no refill condition):

RouteMonthlyAbout a year (12 fills)
Cash, 9 mg$299$3,588
Cash, 14.5 or 17.2 mg, every refill on time$299$3,588
Cash, 14.5 or 17.2 mg, refills late$349$4,188
Commercial plan, copay $125 or less, with card$25$250 on the card's 10 fills, then your plan's copay for any fills after that
Medicare GLP-1 Bridge$50$600

The insured row is the best case, and it depends entirely on your plan's copay. If you have coverage, price that route before you pay cash.

How Foundayo compares with other GLP-1 prices

At a typical maintenance dose Foundayo costs $299 a month in cash, so it is not a budget drug. Brand prices move often, so compare against the current figures:

If you are weighing a pill against a weekly shot on results rather than price, oral GLP-1 pills vs injections covers the trial data. In short: in Lilly's approval announcement, people on the highest dose in the ATTAIN-1 trial lost an average of 12.4% of body weight, against 0.9% on placebo1. Lilly also says Foundayo is the only GLP-1 pill for weight loss that can be taken at any time of day without food or water restrictions1.

Is there a generic or compounded orforglipron?

No approved one. Foundayo was approved on April 1, 20261, and a search of the federal label database returns a single orforglipron label: Lilly's Foundayo7. There is no FDA-approved generic.

Anything sold online as "orforglipron" that is not Foundayo is not an approved drug. The FDA says compounded drugs "are not FDA approved," meaning the agency "does not review compounded drugs for safety, effectiveness or quality before they are marketed," and it has warned companies selling unapproved GLP-1 drugs labeled "for research purposes" or "not for human consumption"10. A low price on an orforglipron powder or capsule is a price for something no regulator has checked.

Where to get a Foundayo prescription

You need a prescription. LillyDirect delivers Foundayo to your home, and retail pharmacies can fill it too12.

Several telehealth programs we review also list Foundayo on their own sites. Check whether the program's monthly fee is charged on top of the drug price before comparing:

Related reading: how to choose a GLP-1 provider without overpaying and the rest of our research index.

Frequently asked questions

How much does Foundayo cost without insurance?

Through Lilly, Foundayo costs $149 at 0.8 mg, $149 at 2.5 mg and $199 at 5.5 mg while a temporary price cut runs through December 31, 2026 (regular prices $199 and $299), $299 at 9 mg, and $349 at 14.5 mg and 17.2 mg, or $299 if you refill within 45 days of your last delivery.

How much is Foundayo with insurance?

If your commercial plan covers Foundayo, Lilly's savings card can bring a one-, two- or three-month fill down to as little as $25. The card pays up to $100 per one-month fill and $1,000 a year across up to 10 fills, excludes Medicare and Medicaid, and expires December 31, 2026.

Does Medicare cover Foundayo?

Through the Medicare GLP-1 Bridge, eligible Part D members can get Foundayo for $50 a month from July 1, 2026 through December 31, 2027. Your prescriber must submit a prior authorization request, and the $50 does not count toward your Part D deductible or out-of-pocket maximum.

Is there a generic or compounded orforglipron?

No approved one. The only orforglipron label in the federal label database is Lilly's Foundayo. The FDA says compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or quality, so anything sold online as orforglipron that is not Foundayo has not been checked by a regulator.

References

  1. Eli Lilly and Company (2026). FDA approves Lilly's Foundayo (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions. PR Newswire. https://www.prnewswire.com/news-releases/fda-approves-lillys-foundayo-orforglipron-the-only-glp-1-pill-for-weight-loss-that-can-be-taken-any-time-of-day-without-food-or-water-restrictions-302731485.html
  2. TrumpRx.gov (2026). Foundayo — Compare Prescription Prices. TrumpRx.gov. https://trumprx.gov/p/foundayo
  3. PrescriberPoint (Eli Lilly program terms) (2026). Foundayo Self-Pay Savings Card Program. PrescriberPoint. https://prescriberpoint.com/therapies/foundayo-8ac446c/financial-assistance/fap-foundayoselfpaysavingscardprogram-copay
  4. GLPChart (2026). Foundayo without insurance: $149 to $349 a month from Lilly (updated September 28, 2026). glpchart.com. https://glpchart.com/savings/foundayo-self-pay/
  5. Honest Care (2026). LillyDirect Foundayo: $149-$349/Mo, No Insurance (April 2026). findhonestcare.com. https://www.findhonestcare.com/treatments/foundayo/cost/lillydirect/
  6. PrescriberPoint (Eli Lilly program terms) (2026). Foundayo Savings Card Program. PrescriberPoint. https://prescriberpoint.com/therapies/foundayo-8ac446c/financial-assistance/fap-foundayosavingscardprogram-copay
  7. Eli Lilly and Company (2026). FOUNDAYO (orforglipron) tablets, film coated — Prescribing Information (revised July 2026). DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62
  8. KFF (2026). What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid. KFF. https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/
  9. Centers for Medicare & Medicaid Services (2026). Coming Soon: CMS to Provide $50 Monthly Access to GLP-1 Medications for Medicare Beneficiaries. CMS.gov. https://www.cms.gov/newsroom/press-releases/coming-soon-cms-provide-50-monthly-access-glp-1-medications-medicare-beneficiaries
  10. U.S. Food and Drug Administration (2026). FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA.gov. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.